Growing the love for investing
Results 31 - 40 of 719 : Previous 1 2 3 4 5 6 7 8 9 Next
Here's How Abbott Laboratories Is Making You So Much Cash
All cash flow is not created equal.
Biotech Pops, Drops, and Break-Ups
Highlighting the day's health-care stories critical to investors.
1 Reason the Street Should Love Eli Lilly's Earnings
Don't just count the cash, time it.
Look here for a clue.
AstraZeneca vs. GlaxoSmithKline
If you could only invest in one of these companies, which would it be?
AZ Sales Flat on Generic Rivals, Pricing Pressures
How is AstraZeneca really doing?
When Getting Beat Down Is No Big Deal
Merck has the bulk to take a beatdown.
Here's How GlaxoSmithKline Is Making You So Much Cash
All cash flow is not created equal.
The U.K.'s No. 1 drug company still looks like a good value.
Why Getting A Flu Shot Is Critical
Vaccines save the lives of millions.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK